Serodiagnosis of Helicobacter pylori-associated gastritis with a monoclonal antibody competitive enzyme-linked immunosorbent assay. 1992

R Negrini, and I Zanella, and A Savio, and C Poiesi, and R Verardi, and S Ghielmi, and A Albertini, and O Sangaletti, and M Lazzaroni, and G Bianchi Porro
Institute of Chemistry, School of Medicine, University of Brescia, Italy.

Forty-nine monoclonal antibodies against Helicobacter pylori were screened to investigate their capacity to be used in enzyme-linked immunosorbent assay (ELISA) competitive systems for the serodiagnosis of Helicobacter pylori infection. On the basis of the inhibition pattern showed by the sera of five infected patients, the antibodies were subdivided into five groups. The immunoblotting analysis showed that the antibodies recognized a total of nine different antigenic determinants. In a study of the reaction of the antibodies with 12 isolates of H. pylori a total of 9 antigenic profiles were identified. Two monoclonal antibodies, HpN44 and HpN45, which recognized a 64-kD protein, were inhibited by all 5 positive sera. Antibody HpN45 was labeled with horseradish peroxidase, and the competitive ELISA was compared with an ordinary indirect ELISA in a study of 102 patients undergoing gastroscopy. Seventy-three patients proved to be infected by H. pylori according to urease or histologic tests. The sensitivity and specificity were 90.4% and 89.6%, respectively, for the indirect ELISA and 100% and 89.6% for the HpN45 competitive assay. The three patients who were 'false seropositive' with both serologic tests had atrophic gastritis. The high diagnostic performance and simplicity of the HpN45 monoclonal competitive ELISA make it suitable for routine serodiagnosis of H. pylori infection.

UI MeSH Term Description Entries
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005756 Gastritis Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders. Gastritides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D015151 Immunoblotting Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies. Dot Immunoblotting,Electroimmunoblotting,Immunoelectroblotting,Reverse Immunoblotting,Immunoblotting, Dot,Immunoblotting, Reverse,Dot Immunoblottings,Electroimmunoblottings,Immunoblottings,Immunoblottings, Dot,Immunoblottings, Reverse,Immunoelectroblottings,Reverse Immunoblottings
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae
D016481 Helicobacter Infections Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease. Infections, Helicobacter,Helicobacter Infection,Infection, Helicobacter

Related Publications

R Negrini, and I Zanella, and A Savio, and C Poiesi, and R Verardi, and S Ghielmi, and A Albertini, and O Sangaletti, and M Lazzaroni, and G Bianchi Porro
January 1988, Scandinavian journal of gastroenterology. Supplement,
R Negrini, and I Zanella, and A Savio, and C Poiesi, and R Verardi, and S Ghielmi, and A Albertini, and O Sangaletti, and M Lazzaroni, and G Bianchi Porro
January 2005, Asian Pacific journal of allergy and immunology,
R Negrini, and I Zanella, and A Savio, and C Poiesi, and R Verardi, and S Ghielmi, and A Albertini, and O Sangaletti, and M Lazzaroni, and G Bianchi Porro
November 1998, Journal of immunoassay,
R Negrini, and I Zanella, and A Savio, and C Poiesi, and R Verardi, and S Ghielmi, and A Albertini, and O Sangaletti, and M Lazzaroni, and G Bianchi Porro
August 1991, Journal of clinical microbiology,
R Negrini, and I Zanella, and A Savio, and C Poiesi, and R Verardi, and S Ghielmi, and A Albertini, and O Sangaletti, and M Lazzaroni, and G Bianchi Porro
February 2014, Monoclonal antibodies in immunodiagnosis and immunotherapy,
R Negrini, and I Zanella, and A Savio, and C Poiesi, and R Verardi, and S Ghielmi, and A Albertini, and O Sangaletti, and M Lazzaroni, and G Bianchi Porro
February 2019, Scientific reports,
R Negrini, and I Zanella, and A Savio, and C Poiesi, and R Verardi, and S Ghielmi, and A Albertini, and O Sangaletti, and M Lazzaroni, and G Bianchi Porro
October 2014, Talanta,
R Negrini, and I Zanella, and A Savio, and C Poiesi, and R Verardi, and S Ghielmi, and A Albertini, and O Sangaletti, and M Lazzaroni, and G Bianchi Porro
November 1991, Chinese medical journal,
R Negrini, and I Zanella, and A Savio, and C Poiesi, and R Verardi, and S Ghielmi, and A Albertini, and O Sangaletti, and M Lazzaroni, and G Bianchi Porro
August 1990, Zhonghua nei ke za zhi,
R Negrini, and I Zanella, and A Savio, and C Poiesi, and R Verardi, and S Ghielmi, and A Albertini, and O Sangaletti, and M Lazzaroni, and G Bianchi Porro
January 1991, Phytochemistry,
Copied contents to your clipboard!